Skip to main content
Medical information Clinical review pending

Genetic Testing

H3N2 Influenza B Qualitative PCR Test

Detects the H3N2 Influenza B virus using a sensitive PCR test. Helps diagnose flu, guide treatment, and monitor outbreaks. Results available same-day (excluding Sundays).

General information only: This page is not a diagnosis or personal medical advice. A qualified clinician should decide whether testing is appropriate and interpret results in context.

Review status: No completed medical review is recorded for this page.

Ask a question
Counselor guidance included Confidential handling Kenya-wide coordination

At a glance

Plan your test

Sample
Buccal Swab or Blood EDTA Tube.
Results
Same-day results, excluding Sundays. Confirm with the laboratory before booking.
Preparation
No specific patient preparation is required. Ensure the Swine Flu / H1N1 Clinical Information Form (Form 25) is completed before testing.
Test priceKSh 7,400

Payment: M-Pesa and card options can be confirmed during booking.

Insurance & government schemes

Is this test covered for you?

We help you verify whether the H3N2 Influenza B Qualitative PCR Test test can be claimed against your insurer, employer scheme or a Kenyan government health scheme — before you book. Coverage depends on your plan, clinical indication and your provider's rules; final approval always rests with them.

Talk to a claims advisor

Providers & schemes we can help you check

Government & public schemes

SHIF — Social Health Insurance Fund Linda Mama EduAfya NHIF (legacy cards)

Eligibility and benefits follow the current rules of the Social Health Authority (SHA) and applicable government programmes.

Private insurers & employer schemes

Jubilee Health AAR APA Britam CIC Madison Resolution Pioneer Minet Old Mutual GA Life Heritage + other licensed insurers

Names shown for identification only — listing does not imply partnership or guarantee of coverage.

Have these ready when we check

  • Insurer or scheme name & policy / member number
  • A clinician's request / prescription for the test
  • Pre-authorisation letter, if your plan requires one

Free coverage check

Ask us to verify your cover

Send your details and our claims team confirms what documents you need and whether pre-authorisation applies — usually the same working day.

+254

Used only to process your coverage check — see our Privacy Policy. Verification support is free and does not guarantee your provider will pay.

01

Start with fit

Is this the right test for you?

The best test starts with a clear clinical question. These are common reasons a clinician or family may consider this test.

  • ✓Suspected influenza infection
  • ✓Presence of flu-like symptoms (fever, cough, sore throat)
  • ✓Monitoring for influenza outbreaks
  • ✓Diagnosis in high-risk individuals
  • ✓Differentiation from other respiratory illnesses
02

In plain language

What this test helps you understand

This test is used to confirm or rule out an active H3N2 Influenza B infection, aiding in clinical diagnosis and management.
The H3N2 Influenza B Qualitative PCR Test is a diagnostic tool used to identify the presence of the H3N2 influenza virus. This test uses Real Time PCR technology for accurate and rapid detection of the virus's genetic material in a patient sample.

Influenza is a contagious respiratory illness, and the H3N2 strain can cause significant health issues, particularly in vulnerable groups. Early and accurate diagnosis is crucial for effective management and preventing the spread of the virus.

This test specifically looks for the genetic material of the H3N2 influenza virus. A positive result confirms the presence of the virus, helping distinguish it from other respiratory infections.

Individuals with flu-like symptoms such as fever, cough, sore throat, body aches, or fatigue are advised to consider this test. It is especially important for high-risk groups like the elderly, young children, pregnant women, and those with chronic health conditions.

Benefits of this test include accurate diagnosis, enabling timely treatment to reduce complications, assisting in public health monitoring, and providing reassurance.

Results are typically available on the same day the sample is received, excluding Sundays. A positive result indicates the virus was detected, while a negative result suggests it was not found in the sample. Discuss your results with your healthcare provider for proper interpretation and guidance.
03

Medical review status

Clinical review pending

A completed medical review is not recorded for this page. No clinician has endorsed the information shown here. Please discuss testing decisions with a qualified healthcare professional.

Meet the DNA Labs Kenya medical team →
04

A simple process

What happens next?

You do not have to navigate the test alone. We help you move from question to next step.

1

Speak with us

We check the test and answer your questions before collection.

2

Give your sample

Choose home collection or a coordinated hub visit in Kenya. We explain whether this test uses a cheek swab or blood draw.

3

Understand your report

A counselor helps you understand the result and the next steps.

05

Choose your collection

Home collection or a lab visit

We will explain the sample, preparation, and next steps before anything is collected.

Home collection

Choose a coordinated visit at home or another convenient location. Our team confirms the appointment and sample requirements in advance.

Lab or hub visit

Prefer to visit a coordinated location? We can guide you to the right hub and explain what to expect when you arrive.

Ask about locations →
PreparationNo specific patient preparation is required. Ensure the Swine Flu / H1N1 Clinical Information Form (Form 25) is completed before testing.
SampleBuccal Swab or Blood EDTA Tube.
MethodologyReal Time Polymerase Chain Reaction (PCR).
PrivacyYour sample and report are handled confidentially. Ask the team how your information is stored and shared.
This test detects the H3N2 Influenza B virus. It may not detect other influenza strains or other respiratory pathogens. A negative result does not completely rule out influenza if the viral load is low or the sample was collected late in the illness.
06

Read your report

What common result terms mean

PositiveA finding was identified. Your clinician or counselor will explain what it means for your care.
NegativeThe specific finding tested for was not identified. It does not rule out every possible cause.
VUSA variant was found, but current evidence is not enough to classify it. Your counselor can explain follow-up.
07

Questions people ask

Frequently asked questions

This test specifically detects the genetic material of the H3N2 Influenza B virus.
Results are typically available on the same day the sample is received, excluding Sundays.
A Buccal Swab or a Blood EDTA Tube is required for this test.
No specific patient preparation is required, but ensure the Swine Flu / H1N1 Clinical Information Form (Form 25) is completed.
A positive result indicates that the H3N2 Influenza B virus was detected in your sample.
08

Collaboration

Open for partnership with hospitals, clinics, doctors & researchers

Whether you are referring patients, building a research programme or supporting students, we work as an extension of your team — with responsive communication and clear scientific standards.

Hospitals & clinics

Referral pathways, coordinated sample logistics and shared reporting that fits your clinical workflow.

Doctors & specialists

LOINC-coded reports, ACMG-based variant classification and a direct scientific line for complex cases.

Research institutions

Sanger sequencing, NGS panels and custom assays — with project design support, batch pricing and agreed turnaround commitments.

Students & academic projects

Discounted laboratory services for college, master's and PhD research projects — including proposal guidance and cost-effective batch testing.

Explore partnerships
09

Trust & transparency

Sources, standards & how this page is maintained

Standards & references

  • ACMG/AMP technical standards for sequence variant interpretation
  • ClinGen curation and gene–disease validity frameworks where applicable
  • LOINC-coded reporting for interoperable results
  • ISO 9001:2015 quality management; ISO 15189 accreditation in progress

Page provenance

  • Last updated: September 27, 2026
  • Medical review: not yet completed
  • Written for patients & clinicians in Kenya; reviewed periodically against current guidance

Medical disclaimer: this page is general information, not a diagnosis or personal medical advice. Testing decisions and result interpretation should be made with a qualified healthcare professional.

Keep exploring

Related tests

View all tests →
Chat on WhatsApp